9 programming-"Multiple"-"U"-"Prof"-"O.P"-"Duke-University"-"U.S"-"FEMTO-ST-institute" positions at Nature Careers in Canada
Sort by
Refine Your Search
-
will establish and maintain an externally-funded research program, teach in the Advanced Health Care Practice Upper Extremity Rehabilitation field and the Master of Physical Therapy (MPT) Program within
-
Nature Careers | Northern British Columbia Fort Nelson, British Columbia | Canada | about 14 hours ago
are recognized and may be counted as an eligible delay. The Canada Research Chair Equity, Diversity, and Inclusion Action Plan guides the University’s efforts to sustain the participation of people with
-
environmental sciences supplemented by research experience. Candidates should be creative, work independently, and have the ability to plan, analyze, and organize multiple projects. The ability to coordinate
-
. The Department of Neurosciences brings together the expertise of multiple teams engaged in cutting-edge research, quality teaching and the promotion of innovation in a multidisciplinary context. Home to a critical
-
Biomolecular Sciences (CBS) in the Faculty of Science with a tenure-track appointment at the rank of Full Professor. The successful candidate will lead a world-class, creative, collaborative research program
-
Nature Careers | Winnipeg Fort Garry NE University of Manitoba, Manitoba | Canada | about 2 months ago
-tier researchers from around the world and support the development high-impact research programs at Canadian universities. A CERC is one of the most prestigious international awards globally, providing
-
innovative Population Health Data Science research programs. We will consider applicants spanning all areas of Population Health Data Science, including complex disease epidemiology, infectious disease
-
. The appointee to the LEEF Chair will be nominated for the Canada Excellence Research Chair (CERC). The CERC program, Canada’s highest research chair appointment, is designed to attract and support world-renowned
-
in preclinical testing. The core technology has FDA approval for Phase I trials, but needs optimization on the I.P., scale manufacture and antigen production areas. Our plan is to leverage emerging